{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895080636288.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.clpt.2005.01.018"}},{"identifier":{"@type":"NAID","@value":"30016994831"}}],"dc:title":[{"@value":"Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1582824501251453440","@type":"Researcher","foaf:name":[{"@value":"M NIEMI"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895080636290","@type":"Researcher","foaf:name":[{"@value":"J BACKMAN"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895080636292","@type":"Researcher","foaf:name":[{"@value":"L KAJOSAARI"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895080636289","@type":"Researcher","foaf:name":[{"@value":"J LEATHART"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895080636295","@type":"Researcher","foaf:name":[{"@value":"M NEUVONEN"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895080636296","@type":"Researcher","foaf:name":[{"@value":"A DALY"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895080636291","@type":"Researcher","foaf:name":[{"@value":"M EICHELBAUM"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895080636288","@type":"Researcher","foaf:name":[{"@value":"K KIVISTO"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895080636294","@type":"Researcher","foaf:name":[{"@value":"P NEUVONEN"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00099236"}],"prism:publicationName":[{"@value":"Clinical Pharmacology & Therapeutics"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2005-06","prism:volume":"77","prism:number":"6","prism:startingPage":"468","prism:endingPage":"478"},"reviewed":"false","createdAt":"2005-05-08","modifiedAt":"2023-11-07","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004231418952960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235933785088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Analysis of the Repaglinide Concentration Increase Produced by Gemfibrozil and Itraconazole Based on the Inhibition of the Hepatic Uptake Transporter and Metabolic Enzymes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236933862400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Direct and Rapid Genotyping of SLCO1B1 388A>G and 521T>C in Human Blood Specimens Using the SmartAmp-2 Method"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004239197828224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Predictability of plasma concentration–time curves in humans using single-species allometric scaling of chimeric mice with humanized liver"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690250138240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693411437952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Substrate-Dependent Inhibition of Organic Anion Transporting Polypeptide 1B1: Comparative Analysis with Prototypical Probe Substrates Estradiol-17β-Glucuronide, Estrone-3-Sulfate, and Sulfobromophthalein"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706367127424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707532955136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Estimation of the Contribution of CYP2C8 and CYP3A4 in Repaglinide Metabolism by Human Liver Microsomes Under Various Buffer Conditions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298755645056256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Positive correlation between organic anion transporter 1B function indicated by plasma concentration of coproporphyrin‐I and blood concentration of cyclosporin A in real‐world patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183363572992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657029121152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prediction of inter-individual variability on the pharmacokinetics of CYP2C8 substrates in human"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657048251008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131416963825024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry"}]},{"@id":"https://cir.nii.ac.jp/crid/1361697223513845376","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pharmacokinetic effects of curcumin on docetaxel mediated by OATP1B1, OATP1B3 and CYP450s"}]},{"@id":"https://cir.nii.ac.jp/crid/1362823123420619776","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans"}]},{"@id":"https://cir.nii.ac.jp/crid/1362823123421175040","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Identification and quantitation of enzyme and transporter contributions to hepatic clearance for the assessment of potential drug-drug interactions"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670321041533312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clarification of the Mechanism of Clopidogrel-Mediated Drug–Drug Interaction in a Clinical Cassette Small-dose Study and Its Prediction Based on In Vitro Information"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204431742208","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Statin-Induced Ca<sup>2+</sup> Release was Increased in B Lymphocytes in Patients who Showed Elevated Serum Creatine Kinase During Statin Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204633124736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205179821824","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Influence of SLCO1B3 Gene Polymorphism on the Pharmacokinetics of Digoxin in Terminal Renal Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205180448896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205181067008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetic, Pharmacodynamic and Toxicological Properties of Anionic Drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679252866176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Transporters involved in hepatobiliary transport of drugs."},{"@language":"ja","@value":"胆汁排泄とトランスポーター"},{"@value":"創薬シリーズ(4)化合物を医薬品にするために必要な薬物動態試験(その4)排泄(3)胆汁排泄とトランスポーター"},{"@language":"ja-Kana","@value":"ソウヤク シリーズ 4 カゴウブツ オ イヤクヒン ニ スル タメニ ヒツヨウ ナ ヤクブツ ドウタイ シケン ソノ 4 ハイセツ 3 タンジュウ ハイセツ ト トランスポーター"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680155477504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"PDZK1 Regulates Organic Anion Transporting Polypeptide Oatp1a in Mouse Small Intestine"},{"@value":"PDZK1 Regulates Organic Anion Transporting Polypeptide Oatpla in Mouse Small Intestine"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680156128000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Genetic Polymorphisms of OATP Transporters and Their Impact on Intestinal Absorption and Hepatic Disposition of Drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680156404480","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Genetic Variations of the SLCO1B1 Gene in the Chinese, Malay and Indian Populations of Singapore"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680156805632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of Genetic Variation in OATP Transporters to Drug Disposition and Response"},{"@value":"Impact of genetic variation in OATP transporters to drug disposition and responses"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680157029632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Importance of OATP1B1 and OATP1B3 in Drug-Drug Interactions"},{"@value":"Clinical Importance of OATP1B1 and OATP1B3 in Drug­Drug Interactions"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680345122432","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"トランスポーターの遺伝子多型が薬物動態・薬効に与えるインパクト～ＯＡＴＰ１Ｂ１，ＢＣＲＰを中心に～"},{"@language":"en","@value":"S12-3. Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetics and Pharmacodynamics of Drugs ∼OATP1B1, BCRP∼"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681105471616","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"薬物の体内動態に及ぼす<i>SLCO1B1</i>遺伝子多型の影響と臨床的意義"},{"@language":"en","@value":"Genetic Polymorphisms of <i>SLCO1B1</i> for Drug Pharmacokinetics and Its Clinical Implications"},{"@value":"薬物の体内動態に及ぼすSLCO1B1遺伝子多型の影響と臨床的意義"},{"@language":"ja-Kana","@value":"ヤクブツ ノ タイナイ ドウタイ ニ オヨボス SLCO1B1 イデンシ タケイ ノ エイキョウ ト リンショウテキ イギ"},{"@value":"ChemInform Abstract: Genetic Polymorphisms of SLCO1B1 for Drug Pharmacokinetics and Its Clinical Implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282763106515968","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Drug Transporter: Its Clinical Significance and Tips for the Prediction of Its Function from <i>In Vitro</i> Data"},{"@language":"ja","@value":"薬物トランスポーター：臨床医療での意義と<i>in vitro</i>実験からの予測の留意点"}]},{"@id":"https://cir.nii.ac.jp/crid/1523106604955256960","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387451026534400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"OATP1B1の遺伝子多型が基質薬物の体内動態・薬効・副作用に与える影響"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.clpt.2005.01.018"},{"@type":"CIA","@value":"30016994831"},{"@type":"CROSSREF","@value":"10.1007/s11095-015-1785-0_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1124/dmd.112.049460_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1248/bpb.b14-00767_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.3109/00498254.2015.1007112_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.3999/jscpt.40.59s_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2017.09.001_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1208/s12248-013-9471-9_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.2133/dmpk.23.406_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1007/s00210-008-0312-9_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1124/dmd.113.052290_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1007/s10928-010-9176-y_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-10-rv-094_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1254/fpj.135.76_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.5551/jat.2048_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1124/dmd.116.070276_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1111/bcp.15640_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1038/jhg.2012.63_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.2133/dmpk.24.37_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-12-rv-099_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.2133/dmpk.23.223_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1016/j.ejps.2018.09.021_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1016/j.xphs.2017.02.013_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-10-rg-074_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1016/j.jpba.2020.113202_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2016.02.005_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.2133/dmpk.23.476_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1248/yakushi.131.1589_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-11-rv-099_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2015.06.003_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2019.11.007_references_DOI_95iNsHqgkDopFIkrhPqqT54lYxX"}]}